Cross Country Healthcare (CCRN) Misses Q3 EPS by 2c; offers guidance
Tweet
Share
E-mailGet Alerts CCRN Hot Sheet
Price: $13.17 --0%
Revenue Growth %: -11.6%
Financial Fact:
Selling, general and administrative expenses: 45.92M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -11.6%
Financial Fact:
Selling, general and administrative expenses: 45.92M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Cross Country Healthcare (NASDAQ: CCRN) reported Q3 EPS of $0.39, $0.02 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $442.29 million versus the consensus estimate of $443.9 million.
GUIDANCE:
Cross Country Healthcare sees Q4 2023 EPS of $0.25-$0.35, versus the consensus of $0.45. Cross Country Healthcare sees Q4 2023 revenue of $400-410 million, versus the consensus of $439.2 million.
For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
- Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
